Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    16912128 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting Efficacy Study of Sitagliptin to Prevent New-onset Diabetes After Kidney Transplant
Condition: Posttransplant Diabetes Mellitus
Interventions: Drug: Sitagliptin;   Drug: Placebo

Study has passed its completion date and status has not been verified in more than two years.